These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 17026457)
1. Novel approaches for the management of patients with Ewing sarcoma. Avigad S; Yaniv I Future Oncol; 2006 Oct; 2(5):659-65. PubMed ID: 17026457 [TBL] [Abstract][Full Text] [Related]
2. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child. Pochon C; Martelli H; Mussini C; Pariente D; Heymann MF; Corradini N J Pediatr Hematol Oncol; 2015 Jul; 37(5):411-3. PubMed ID: 25411865 [No Abstract] [Full Text] [Related]
3. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination. Greve T; Wielenga VT; Grauslund M; Sørensen N; Christiansen DB; Rosendahl M; Yding Andersen C Eur J Cancer; 2013 May; 49(8):1932-8. PubMed ID: 23452988 [TBL] [Abstract][Full Text] [Related]
4. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038 [TBL] [Abstract][Full Text] [Related]
5. Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth. Surdez D; Benetkiewicz M; Perrin V; Han ZY; Pierron G; Ballet S; Lamoureux F; Rédini F; Decouvelaere AV; Daudigeos-Dubus E; Geoerger B; de Pinieux G; Delattre O; Tirode F Cancer Res; 2012 Sep; 72(17):4494-503. PubMed ID: 22930730 [TBL] [Abstract][Full Text] [Related]
7. Incidence and prognostic value of tumour cells detected by RT-PCR in peripheral blood stem cell collections from patients with Ewing tumour. Vermeulen J; Ballet S; Oberlin O; Peter M; Pierron G; Longavenne E; Laurence V; Kanold J; Chastagner P; Lejars O; Blay JY; Marec-Berard P; Michon J; Delattre O; Schleiermacher G Br J Cancer; 2006 Nov; 95(10):1326-33. PubMed ID: 17088915 [TBL] [Abstract][Full Text] [Related]
8. In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Pessetto ZY; Chen B; Alturkmani H; Hyter S; Flynn CA; Baltezor M; Ma Y; Rosenthal HG; Neville KA; Weir SJ; Butte AJ; Godwin AK Oncotarget; 2017 Jan; 8(3):4079-4095. PubMed ID: 27863422 [TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular features of Ewing sarcoma in a patient with triple-X syndrome. Patiño-García A; López de Mesa R; de Alava E; Sierrasesúmaga L Cancer Genet Cytogenet; 1999 Sep; 113(2):188-90. PubMed ID: 10484990 [TBL] [Abstract][Full Text] [Related]
10. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma. Huang L; Nakai Y; Kuwahara I; Matsumoto K Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085 [TBL] [Abstract][Full Text] [Related]
11. 'Like--but oh, how different!'. Gaffney EF Am J Surg Pathol; 2000 Feb; 24(2):322-3. PubMed ID: 10680910 [No Abstract] [Full Text] [Related]
12. Twenty Years on: What Do We Really Know about Ewing Sarcoma and What Is the Path Forward? Lawlor ER; Sorensen PH Crit Rev Oncog; 2015; 20(3-4):155-71. PubMed ID: 26349414 [TBL] [Abstract][Full Text] [Related]
13. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222 [TBL] [Abstract][Full Text] [Related]